• Activating the patient’s immune system
    to fight cancer

Mesothelioma 30-month data

The 30-month data from the mesothelioma trial was released December 2021. See press release here.
For a video presentation of the 24-month data from June 2021, please see links below:

Q4 Fourth Quarter 2022

Targovax announced its fourth quarter 2022 results on Thursday 16 February 2023.

Webcast: 10:00 a.m. CET the same day

Webcast presentation on Xtrainvestor

For a company presentation in Norwegian, please see video below.